Health in Togo 1,217 indicators covering health for Togo. IndicatorLatest Year10-yr change Rank Incidence of malaria 249.25 per 1,000 population at risk 2024 down 32.4% 20th Reported number of children receiving antiretroviral therapy 3,604 2025 up 17.9% 26th Concentrations of fine particulate matter 34.67 2023 up 16.7% 32nd Death rate road traffic injuries 28.7 2019 down 7.7% 33rd New or unknown treatment history cases: Pulmonary, bacteriologically 2,526 2023 up 30.6% 82nd Cholera case fatality rate 12.5 2021 — 3rd Life satisfaction vs life expectancy 62.74 2023 up 7.5% 213th Estimate of current cigarette smoking prevalence 3.1% 2030 down 22.5% 155th Estimate of current cigarette smoking prevalence (%) 3.4% 2030 down 24.4% 156th Tb patients tested positive for hiv 332 2021 down 50.2% 59th Number of children aged 6-59 months with anaemia 871.56 2019 up 13.4% 49th Prevalence of anaemia in children aged 6-59 months 72.4% 2019 down 1.6% 7th Number of deaths attributed to non-communicable diseases, by type of 3,352 2019 up 37.6% 132nd Hepatitis B surface antigen (HBsAg) prevalence 1.4% 2024 down 30.0% 19th Mean hemoglobin level of children aged 6-59 months 100 2019 up 1.0% 185th Estimated number of MDR/RR-TB incident cases 26 2024 down 66.2% 124th Mortality caused by road traffic injury 28.7 per 100,000 population 2019 down 8.3% 33rd Mortality caused by road traffic injury, female 17.8 per 100,000 female population 2019 down 9.2% 19th Mortality caused by road traffic injury, male 39.6 per 100,000 male population 2019 down 8.1% 35th Ipv vaccine coverage 90 2024 up 350.0% 115th Tb patients living with hiv receiving art 328 2021 down 26.9% 57th HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 up 31.6% 1st Hospital beds 3.3 2022 down 47.2% 148th Treatment success rate for patients treated for MDR-TB 60.0% 2022 down 40.0% 120th New leprosy case detection rate per 1 000 000 population 7.78 2024 down 43.9% 49th Treatment success rate: HIV-positive TB cases 78 2023 — 61st Prevalence of wasting, weight for height 5.7% 2017 down 5.0% 36th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 69.0% 2025 — 132nd International Health Regulations core capacity scores, SPAR version 40 2025 — 112th Prevalence of underweight, weight for age 15.2% 2017 down 25.9% 30th Leprosy registered prevalence rate per 1 000 000 population 8.41 2024 down 39.4% 54th Leprosy - Number of new leprosy cases among children 4 2024 — 44th Leprosy - Number of cases registered for treatment 80 2024 down 17.5% 56th New leprosy child case detection rate (less than 15 years of age) per 1.06 2024 — 45th Children (0-14) living with HIV 5,500 2024 down 45.0% 31st Ipv1 number unvaccinated 21,730 2023 down 87.8% 74th Children living with hiv 5,500 2024 down 45.0% 31st Contraceptive prevalence, any method 23.8% 2017 up 45.2% 101st Children (ages 0-14) newly infected with HIV 530 2024 down 19.7% 28th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 5.8% 2024 down 29.3% 145th Number of children newly infected with hiv 530 2024 down 19.7% 28th Share of children under fifteen years old with hiv 526.03 2024 down 19.8% 28th Number of female leprosy new cases 36 2024 down 14.3% 48th Estimated number of malaria deaths 3,486 2024 down 32.0% 27th Estimated number of malaria cases 2.37 million 2024 down 14.0% 26th National smoking ban: NUMBER OF PLACES SMOKE-FREE 4 2022 unchanged 112th Contraceptive prevalence, any modern method 21.4% 2017 up 90.3% 94th Number of prevalent tuberculosis cases 5,800 2014 up 31.8% 97th Estimated malaria incidence 249.25 2024 down 32.4% 20th Estimated malaria mortality rate 36.64 2024 down 46.6% 22nd Number of new G2D leprosy cases 28 2024 up 33.3% 33rd Leprosy - New leprosy cases with G2D rate per 1 000 000 population 2.94 2024 up 1.3% 23rd Inflation-adjusted prices for most sold brand of cigarettes: Prices 2.69 2022 up 25.7% 158th Taxes as a % of price: total tax 24.9% 2022 up 12.3% 163rd Taxes as a % of price: value added tax 15.2% 2022 unchanged 50th Taxes as a % of price: ad valorem excise 8.9% 2022 up 32.4% 87th Taxes as a % of price: specific excise 0.0% 2022 — 134th Taxes as a % of price: import duties 0.0% 2022 — 37th Taxes as a % of price: other taxes 0.7% 2022 up 305.9% 43rd ← Previous Page 15 of 21 Next →